Ubrelvy 00023-6498
Generic: Ubrogepant
Product NDC
00023-6498- Manufacturer
- Allergan, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 23, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA211765
Need to source Ubrelvy? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ubrogepant | 50 mg/1 |
Drug Class
Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
Packaging Options(5)
1 PACKET in 1 BOX (0023-6498-01) / 1 TABLET in 1 PACKET
4 PACKET in 1 BOX (0023-6498-04) / 1 TABLET in 1 PACKET
10 PACKET in 1 BOX (0023-6498-10) / 1 TABLET in 1 PACKET (0023-6498-02)
16 PACKET in 1 BOX (0023-6498-16) / 1 TABLET in 1 PACKET (0023-6498-02)
30 PACKET in 1 BOX (0023-6498-30) / 1 TABLET in 1 PACKET (0023-6498-02)